Pilot randomised trial of a brief intervention for co-morbid substance misuse in psychiatric inpatient settings

Hermine Graham, Alexandre Copello, Maximillian Birchwood, Emma Griffith, Nick Freemantle, Paul Mccrone, Latoya Clarke, Kathryn Walsh, Chrysi Stefanidou, Arsal Rana

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Abstract

Objective
This proof of principle study evaluated the effectiveness and feasibility of a brief motivational intervention, delivered in mental health in-patient settings, to improve engagement in treatment for drug and alcohol misuse.

Method
A randomised controlled trial using concealed randomisation, blind, independent assessment of outcome at 3 months. Participants were 59 new adult admissions, to six acute mental health hospital units in one UK mental health service, with schizophrenia related or bipolar disorder diagnoses, users of community mental health services and also misusing alcohol and/or drugs. Participants were randomised to Brief Integrated Motivational Intervention (BIMI) with Treatment As Usual (TAU), or TAU alone. The BIMI took place over a 2-week period and encouraged participants to explore substance use and its impact on mental health.

Results
Fifty-nine in-patients (BIMI n = 30; TAU n = 29) were randomised, the BIMI was associated with a 63% relative odds increase in the primary outcome engagement in treatment [OR 1.63 (95% CI 1.01–2.65; P = 0.047)], at 3 months. Qualitative interviews with staff and participants indicated that the BIMI was both feasible and acceptable.

Conclusion
Mental health hospital admissions present an opportunity for brief motivational interventions focussed on substance misuse and can lead to improvements in engagement.
Original languageEnglish
Pages (from-to)298-309
JournalActa Psychiatrica Scandinavica
Volume133
Issue number4
Early online date21 Nov 2015
DOIs
Publication statusPublished - Apr 2016

Fingerprint

Dive into the research topics of 'Pilot randomised trial of a brief intervention for co-morbid substance misuse in psychiatric inpatient settings'. Together they form a unique fingerprint.

Cite this